Previous 10 | Next 10 |
Sorrento Therapeutics (NASDAQ: SRNE ) +36% in reaction to reports that it has discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of COVID-19. More news on: Sorrento Therapeutics, Inc., Moderna, Inc., Fulgent Genetics, Inc., Stocks on the ...
TEMPLE CITY, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing solutions, today announced that its subsidiary, Fulgent Therapeutics, LLC, has received ...
The FDA has authorized the first at-home sample collection kit that can be used with multiple authorized COVID-19 lab tests. More news on: Fulgent Genetics, Inc., Healthcare stocks news, Read more ...
Gainers: Portola Pharmaceuticals (NASDAQ: PTLA ) +130% . More news on: Portola Pharmaceuticals, Inc., CleanSpark, Inc., Genprex, Inc., Stocks on the move, , Read more ...
Image source: The Motley Fool. Fulgent Genetics, Inc. (NASDAQ: FLGT) Q1 2020 Earnings Call May 4, 2020 , 4:30 p.m. ET Operator Continue reading
Fulgent Genetics, Inc. (FLGT) Q1 2020 Earnings Conference Call May 04, 2020, 04:30 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - Chief Commercial Officer Conference Call Participants Erin Wright - Credit Suisse St...
Fulgent Genetics (NASDAQ: FLGT ): Q1 Non-GAAP EPS of -$0.03 misses by $0.05 ; GAAP EPS of -$0.09 misses by $0.06 . More news on: Fulgent Genetics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
TEMPLE CITY, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2020 financial results after the market closes on Monday May 4, 2020. The co...
TEMPLE CITY, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced that i...
Fulgent Genetics (FLGT) had a very good 2019, but it won't come as a surprise to realize that 2020 is going to be considerably more challenging. At the time of the Q4CC (March 10), the US was still a different place, so management did not see much impact of the coronavirus. In fact, they wer...
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...
Total Revenue of $64.5 million Core Revenue grows 1% year-over-year to $63.2 million Reiterates Full Year 2024 Core Revenue Guidance of $280 million Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a...
2024-05-01 06:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...